DOCU vs ERNA · P/E 15, rev $2.98B vs P/E 0.0, rev $582.0K
DocuSign Inc (DOCU) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported DOCU revenue for 2025-01-31 was $2.98B. Net income was $1.07B. Revenue was up 7.8% from 2024-01-31 to 2025-01-31. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the DOCU and ERNA stock pages for the full models.
Not investment advice.